Compare AMC ENTERTAINMENT HOLDINGS, INC. (AMC) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AMC ENTERTAINMENT HOLDINGS, INC. vs Mesoblast Limited — how do they compare? AMC ENTERTAINMENT HOLDINGS, INC. trades at $2.41 (market cap $2.14B), while Mesoblast Limited trades at $16.96 (market cap $2.21B). The key difference: AMC ENTERTAINMENT HOLDINGS, INC. and Mesoblast Limited are close in size by market cap, and AMC ENTERTAINMENT HOLDINGS, INC. pays a 0.11% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| AMC | MESO | |
|---|---|---|
Market Cap | $2.14B | $2.21B |
Sector | Media | Technology |
52-Week High | $3.15 | $20.96 |
52-Week Low | $0.95 | $12.88 |
Enterprise Value | $9.08B | $2.21B |
Dividend Yield | 0.11% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMC trades at $2.42, down 6.56% today, yet maintains a bullish technical signal with strong recent earnings beats. The company reported record Q2 2026 revenue and EBITDA, driven by surging attendance and premium screen growth. However, negative net income and substantial debt of $4.01 billion highlight financial strain. Analyst consensus is a $3.00 price target with mixed ratings (32% Buy, 46% Hold).
The outlook hinges on sustained box office recovery and cash flow improvement, with management citing a potential cash-flow breakthrough. Key risks include high leverage, dependence on film slate success, and meme-stock volatility. Upside exists if operational momentum continues, but the negative equity position warrants caution.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AMC ENTERTAINMENT HOLDINGS, INC.
AMC Entertainment Holdings, Inc. operates as a holding company. The Company, through its subsidiaries, provides theatrical exhibition, movie screening, food distribution, online ticket booking, and other related services. AMC Entertainment offers movie theaters worldwide.
Read more on AMC →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
